CompoundLink @CompoundLink

Patients, providers, compounding facilities and suppliers can connect via the CompoundLink community, to discuss and find solutions to fulfill unmet needs. Joined March 2020

Tweets

67
Followers

26
Following

250
Likes

10

CompoundLink @CompoundLink

5 years ago

An Exciting New Chapter in OTC Drug History: OTC Monograph Reform in the CARES Act fda.gov/news-events/fd…

0 0 0 0 0

“Agency Information Collection Activities; Proposed Collection; Comment Request; Obtaining Information To Understand Challenges and Opportunities Encountered by Compounding Outsourcing Facilities”...regulations.gov/document?D=FDA…

0 0 0 0 0

CompoundLink @CompoundLink

5 years ago

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder fda.gov/drugs/drug-saf…

0 0 0 0 0

CompoundLink @CompoundLink

5 years ago

Exclusive: After pandemic, U.S. senators want review of drug supply chain | Article [AMP] | Reuters reuters.com/article/us-hea…

0 0 0 0 0

CompoundLink @CompoundLink

5 years ago

Remdesivir by Gilead Sciences: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of Treatment fda.gov/safety/medical…

0 0 0 0 0

CompoundLink @CompoundLink

5 years ago

FDA revokes emergency use authorization for chloroquine, hydroxychloroquine fxn.ws/3e5TKBM

0 0 0 0 0

CompoundLink @CompoundLink

5 years ago

Rare Disease Therapy Development and Access Remain Top FDA Priorities During COVID-19 fda.gov/news-events/fd…

0 0 0 0 0

CompoundLink @CompoundLink

5 years ago

“Policy Updates to FDA Guidances on Compounding Certain Drugs for Hospitalized COVID-19 Patients” fda.gov/drugs/coronavi…

0 0 0 0 0

CompoundLink @CompoundLink

5 years ago

Updated: Temporary Policy Regarding Non-Standard PPE Practices for Sterile Compounding by Pharmacy Compounders not Registered as Outsourcing Facilities During the COVID-19 Public Health Emergency fda.gov/regulatory-inf…

0 0 0 0 0

CompoundLink @CompoundLink

5 years ago

FDA Announces Latest Step Toward Finalizing Memorandum of Understanding with States Addressing Compounded Drug Distribution, While Preserving Access fda.gov/news-events/fd…

0 0 0 0 0

CompoundLink @CompoundLink

5 years ago

“Morphine Sulfate and Epinephrine added to FDA guidances on compounding certain drugs for hospitalized COVID-19 patients”... bit.ly/35TM3ev and bit.ly/2yM5vhe

0 0 0 0 0

CompoundLink @CompoundLink

5 years ago

COVID-19 drug shortages reveal potential issues with global supply chain youtu.be/k26Dfok8Uts via @YouTube

0 0 0 0 0

CompoundLink @CompoundLink

5 years ago

Famotidine Shortages Continue Amid Pandemic drugtopics.com/article/famoti…

0 0 0 0 0

CompoundLink @CompoundLink

5 years ago

CDC - Recommended Guidance for Extended Use and Limited Reuse of N95 Filtering Facepiece Respirators in Healthcare Settings - NIOSH Workplace Safety and Health Topic cdc.gov/niosh/topics/h… via @CDCgov

0 0 0 0 1

CompoundLink @CompoundLink

6 years ago

Outsourcing facilities that produce compounded drugs play a pivotal role in the coronavirus pandemic by ensuring that hospitals have access to critical medications. businesswire.com/news/home/2020…

0 0 0 0 0

Alliance for Pharmacy Compounding @a4pcrx

6 years ago

APC & NASPA have released suggested state bd of pharmacy guidelines for overseeing 503A sterile compounders providing COVID shortage drugs to hospitals under FDA temporary guidance. @InHealthPolicy reports here: insidehealthpolicy.com/share/114615 @StatePharmacy @Commpharmacy @pharmacists

0 2 1 0 0

CompoundLink @CompoundLink

6 years ago

Temporary Policy on Repackaging or Combining Propofol Drug Products During the COVID-19 Public Health Emergency fda.gov/regulatory-inf…

0 0 0 0 0

CompoundLink @CompoundLink

6 years ago

Coronavirus (COVID-19) Update: FDA Continues to Ensure Availability of Alcohol-Based Hand Sanitizer During the COVID-19 Pandemic, Addresses Safety Concerns fda.gov/news-events/pr…

0 0 0 0 0

CompoundLink @CompoundLink

6 years ago

Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems fda.gov/safety/medical…